Events /// Investor News /// Investment Case /// Resources
Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders.
Investor News
Share Price / Index
January 16, 2026
Bayer welcomes the U.S. Supreme Court decision to review the Durnell case in the Roundup™ litigation
January 16, 2026
Not intended for U.S. and UK Media
Eylea™ 8 mg approved in the EU for third retinal indication
January 06, 2026
Not intended for U.S. and UK Media
Bayer receives Breakthrough Therapy Designation in the U.S. and China for sevabertinib as a first-line treatment for patients with HER2-mutant non-small cell lung cancer
Discover More
